⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
VALN News
Valneva SE American Depositary Shares
Elaris Secures Exclusive Global License from Valneva for C. difficile Vaccine Program
prnewswire.com
VALN
Valneva Reports Full Year 2025 Audited Consolidated Financial Results
globenewswire.com
VALN
Valneva Reports Full Year 2025 Audited Consolidated Financial Results
globenewswire.com
VALN
Valneva to Report Full Year 2025 Consolidated Financial Results on March 18, 2026
globenewswire.com
VALN
Valneva to Report Full Year 2025 Consolidated Financial Results on March 18, 2026
globenewswire.com
VALN
Valneva to Participate in Upcoming Investor Conferences
globenewswire.com
VALN
Valneva to Participate in Upcoming Investor Conferences
globenewswire.com
VALN
Valneva Reports Preliminary Unaudited 2025 Revenue and Cash and Provides 2026 Outlook
globenewswire.com
VALN
Valneva Provides Update on Recommendations for Use of IXCHIQ® in the United Kingdom
globenewswire.com
VALN
Valneva and Instituto Butantan Announce Initiation of a Pilot Vaccination Campaign in Brazil with Single-Shot Chikungunya Vaccine IXCHIQ®
globenewswire.com
VALN